Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert J Tripolt

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Plos One|October 29, 2015
Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot StudyVanessa Stadlbauer, Bettina Leber, Sandra Lemesch, et al.
Cardiovascular Diabetology|May 20, 2022
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp studyCeren Eyileten, Zofia Wicik, Disha Keshwani, et al.
Diabetes, Obesity & Metabolism|October 3, 2024
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT studyHarald Sourij, Kehkishan Azhar, Faisal Aziz, et al.
Frontiers in Endocrinology|July 23, 2021
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled TrialOthmar Moser, Max L Eckstein, Alexander Mueller, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Viruses|January 21, 2023
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 VaccinationMargret Paar, Faisal Aziz, Caren Sourij, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
NEJM Evidence|September 1, 2024
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-DsMartin Benedikt, Abderrahim Oulhaj, Ursula Rohrer, et al.
Nutrients|February 11, 2023
Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People-A Cohort TrialNorbert J Tripolt, Sebastian J Hofer, Peter N Pferschy, et al.
Journal of Clinical Medicine|December 11, 2025
Impact of Ertugliflozin on Cardiac Structure and Function in Patients with ICDs/CRT-Ds Assessed by Echocardiography: A Post Hoc Sub-Analysis of the ERASe TrialViktoria Santner, Ewald Kolesnik, Martin Benedikt, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos One|October 29, 2015
Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot StudyVanessa Stadlbauer, Bettina Leber, Sandra Lemesch, et al.
Cardiovascular Diabetology|May 20, 2022
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp studyCeren Eyileten, Zofia Wicik, Disha Keshwani, et al.
Diabetes, Obesity & Metabolism|October 3, 2024
Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT studyHarald Sourij, Kehkishan Azhar, Faisal Aziz, et al.
Frontiers in Endocrinology|July 23, 2021
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled TrialOthmar Moser, Max L Eckstein, Alexander Mueller, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp studyFelix Aberer, Peter N Pferschy, Norbert J Tripolt, et al.
Viruses|January 21, 2023
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 VaccinationMargret Paar, Faisal Aziz, Caren Sourij, et al.
American Heart Journal|January 19, 2022
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) - A phase III studyDirk von Lewinski, Norbert J Tripolt, Harald Sourij, et al.
NEJM Evidence|September 1, 2024
Ertugliflozin to Reduce Arrhythmic Burden in Patients with ICDs/CRT-DsMartin Benedikt, Abderrahim Oulhaj, Ursula Rohrer, et al.
Nutrients|February 11, 2023
Glucose Metabolism and Metabolomic Changes in Response to Prolonged Fasting in Individuals with Obesity, Type 2 Diabetes and Non-Obese People-A Cohort TrialNorbert J Tripolt, Sebastian J Hofer, Peter N Pferschy, et al.
Journal of Clinical Medicine|December 11, 2025
Impact of Ertugliflozin on Cardiac Structure and Function in Patients with ICDs/CRT-Ds Assessed by Echocardiography: A Post Hoc Sub-Analysis of the ERASe TrialViktoria Santner, Ewald Kolesnik, Martin Benedikt, et al.
Pageof 4